Insider Donald Morel Sells Shares of Stevanato Group

On June 15, 2026, Donald Morel, an insider at Stevanato Group S.p.A. (NYSE:STVN), sold 1,493 shares of the company. The shares were sold at an average price of $17.09, totaling approximately $25,515.37. This transaction was not part of a pre-planned trading program.

Other Institutional Activity in Stevanato Group

Several institutional investors have adjusted their positions in Stevanato Group. Conestoga Capital Advisors, LLC increased its holdings by 602,050 shares, bringing its total to 8,491,751 shares valued at about $116.76 million, reflecting a 7.6% increase. Neuberger Berman Group LLC trimmed its stake by 312,219 shares, ending with 4,475,492 shares worth approximately $61.54 million, a 6.5% decrease. TimesSquare Capital Management, LLC slightly reduced its position by 10,605 shares for a new total of 3,489,716 shares valued at $47.98 million, a 0.3% decrease. T. Rowe Price Investment Management, Inc. cut its holdings by 698,724 shares to 3,224,908 shares, valued at $44.34 million, a 17.8% decrease. Meanwhile, BAMCO Inc /NY/ grew its stake by 498,714 shares, ending with 2,500,438 shares worth $34.38 million, a 24.9% increase.

Stevanato Group S.p.A. Stock Down 12.6%

Shares of Stevanato Group traded near $18.39 on Friday. The company, with a market cap of $5.02 billion, has a P/E ratio of 31.71 and a forward P/E of 21.95. Its beta stands at 0.776, indicating lower volatility compared to the market. Over the past 52 weeks, the stock has ranged from a low of $12.89 to a high of $28.00. The 50-day moving average is $17.39, and the 200-day moving average is $19.57. Stevanato Group maintains a current ratio of 1.63 and a quick ratio of 1.11, with a debt-to-equity ratio of 29.43.

Recent Earnings

In the most recent earnings report, Stevanato Group posted revenue of approximately $1.20 billion, reflecting a growth of 6.6%. The company achieved a net margin of 11.75% and a return on equity of 9.59%. Earnings per share came in at $0.58. The next earnings report is expected on May 7, 2026.

Dividend

Stevanato Group offers an annual dividend rate of $0.06 per share, yielding 0.34%. The dividend payout ratio is 10.59%, indicating a conservative approach to returning profits to shareholders.

Insider Buying and Selling at Stevanato Group S.p.A.

On June 15, several insiders, including Karen Flynn, William Federici, and Madhavan Balachandran, sold 1,493 shares each at the same price of $17.09. On June 12, William Federici acquired 4,975 shares, and Marco Dal Lago, the CFO, purchased 2,356 shares, both at no cost.

Analysts Set New Price Targets

On June 16, 2026, TD Cowen initiated coverage on Stevanato Group with a 'buy' rating and a price target of $25. Wolfe Research assumed coverage with a 'buy' rating and a $21 target on June 2. The consensus among analysts is a 'buy' rating, with a mean price target of $24.45, based on 10 analyst opinions.

About Stevanato Group

Stevanato Group S.p.A. is a healthcare company based in Piombino Dese, Italy. It designs, manufactures, and distributes products and processes for the biopharma and healthcare industries. Its offerings include drug containment solutions, in-vitro diagnostic products, and drug delivery systems. The company operates globally in regions such as Europe, North America, and Asia Pacific. Founded in 1949, Stevanato Group employs over 6,000 people and is led by CEO Franco Stevanato.

Bottom Line

Donald Morel's recent sale of Stevanato Group shares is a notable insider transaction. Investors often watch insider activity closely, though such sales can happen for many reasons. With a strong presence in the healthcare sector and ongoing analyst interest, Stevanato Group remains a company to watch. Remember, insider transactions are reported after the fact and do not necessarily indicate future stock performance.